Showing 34,667 results

New & experimental hepatitis C treatment

Daclatasvir TRIO regimen has good cure rates for hepatitis C patients with or without cirrhosis

News
11 November 2014
Hepatitis C transmission & prevention

Young drug injectors on opioid maintenance therapy have lower risk of hepatitis C infection

News
11 November 2014
Epidemiology & behaviour

New HIV infections falling in US, MSM still top list, CDC reports

Editor's pick
International AIDS Society
11 November 2014
Hepatitis C treatment

New HCV drugs pass muster in real world

Editor's pick
MedPage Today
11 November 2014
The search for a cure

Researchers See New Avenue For HIV Cure: Endogenization

Editor's pick
AIDSmeds.com
11 November 2014
HIV & criminal law

Suraj Madoori: Media-Driven Stigma Continues With New HIV Criminalization Case

Editor's pick
Huffington Post
11 November 2014
Vaginal rings & topical PrEP

Current State of Rectally-applied PrEP

Editor's pick
BETA blog
11 November 2014
People who inject drugs

More naloxone programmes to prevent the increasing opiate-overdose deaths in England are ungently needed

Editor's pick
International Doctors for Healthier Drug Policies
11 November 2014
New & experimental hepatitis C treatment

New pill that can cure hepatitis C approved for patients in Scotland

Editor's pick
STV
11 November 2014
Low & theoretical transmission risks

An HIV Transmission Case Possibly Associated with Manicure Care

Editor's pick
AIDS Research and Human Retroviruses
11 November 2014
New & experimental hepatitis C treatment

Merck’s four-week treatment for hepatitis C misses the mark

Editor's pick
Wall Street Journal
11 November 2014
Sexually transmitted infections prevention

Missed HPV vaccination opportunities: a consequence of avoiding awkward conversations

Editor's pick
BMJ
11 November 2014
Epidemiology & behaviour

More straight people than gay people being diagnosed with HIV in Kent

Editor's pick
Pink News
11 November 2014
Improving HIV care

South Africa: SA Can Overcome HIV Challenge - Deputy President

Editor's pick
AllAfrica.com
11 November 2014
Vaginal rings & topical PrEP

Misunderstanding of questions regarding anal sex in microbicide HIV prevention trial

News
10 November 2014
New & experimental HIV treatments

Once-daily dolutegravir superior to darunavir/ritonavir in 96-week follow-up

News
10 November 2014
New & experimental HIV treatments

Doravirine works as well as efavirenz with fewer CNS side-effects

News
10 November 2014
Harm reduction

Addiction services in England: in need of an intervention

Editor's pick
The Lancet Psychiatry
10 November 2014
New & experimental hepatitis C treatment

Phase 3 UNITY Trials Demonstrate High Cure Rates for Investigational, All-Oral Daclatasvir TRIO Fixed-Dose Combination in Genotype 1 Hepatitis C Patients, Including Those with Cirrhosis

Editor's pick
Bristol-Myers Squibb press release
10 November 2014
New & experimental hepatitis C treatment

ALLY Trial Demonstrates High Cure Rates for Investigational Daclatasvir and Sofosbuvir Combination among Genotype 3 Hepatitis C Patients

Editor's pick
Bristol-Myers Squibb press release
10 November 2014
New & experimental hepatitis C treatment

Achillion Reports 100% SVR12 in a Phase 2 Combination Study With ACH-3102 at the Liver Meeting 2014 (AASLD)

Editor's pick
Achillion press release
10 November 2014
HIV prevention policy

Time for the UK to get ready for PrEP

Editor's pick
The Lancet HIV
10 November 2014
New & experimental hepatitis C treatment

Merck's Four-Week Hepatitis C Regimen Fails to Top Gilead

Editor's pick
Bloomberg
10 November 2014
The search for a cure

Scientists see mechanism for spontaneous HIV 'cure'

Editor's pick
AFP / Yahoo News
10 November 2014